Silo pharma, inc. engages donohoe advisory to assist with its efforts to obtain a listing on a national stock exchange

Englewood cliffs nj, dec. 14, 2021 (globe newswire) -- silo pharma, inc. (otcqb: silo) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, announced the engagement of donohoe advisory associates llc ("donohoe") for consulting and advisory services in connection with the potential up-listing of silo's common shares on the nasdaq stock market.
SILO Ratings Summary
SILO Quant Ranking